Comparison of two once-daily regimen Consisting of nelfinavir, didanosine and stavudine in antiretroviral therapy-naïve adults: 48-week results from the antiretroviral evaluation study (ARES)

Translated title of the contribution: Comparison of two once-daily regimen Consisting of nelfinavir, didanosine and stavudine in antiretroviral therapy-naïve adults: 48-week results from the antiretroviral evaluation study (ARES)

S.H. Lowe, A.M.J. Wensing, E.A. Hassink, R.W. ten Kate, C. Richer, G. Schreij, P.P. Koopmans, J.R. Juttmann, I. van der Tweel, J.M.A. Lange, J.C.C. Borleffs

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionComparison of two once-daily regimen Consisting of nelfinavir, didanosine and stavudine in antiretroviral therapy-naïve adults: 48-week results from the antiretroviral evaluation study (ARES)
Original languageUndefined/Unknown
Pages (from-to)235-245
Number of pages11
JournalHIV Clinical Trials
Volume6
Issue number5
Publication statusPublished - 2005

Cite this